{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:10:41Z","timestamp":1791299441160,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T00:00:00Z","timestamp":1408579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T00:00:00Z","timestamp":1408579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep06155","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T09:36:34Z","timestamp":1408613794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Feasibility of Amylin Imaging in Pancreatic Islets with \u03b2-Amyloid Imaging Probes"],"prefix":"10.1038","volume":"4","author":[{"given":"Masashi","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,21]]},"reference":[{"key":"BFsrep06155_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw, J. E., Sicree, R. A. & Zimmet, P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4\u201314 (2010).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFsrep06155_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMcp1103643","volume":"367","author":"SE Izucchi","year":"2012","unstructured":"Izucchi, S. E. Clinical practice. Diagnosis of diabetes. N. Engl. J. Med. 367, 542\u2013550 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep06155_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse, J. B. et al. How do we define cure of diabetes? Diabetes Care 32, 2133\u20132135 (2009).","journal-title":"Diabetes Care"},{"key":"BFsrep06155_CR4","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00125-012-2466-8","volume":"55","author":"JJ Meier","year":"2012","unstructured":"Meier, J. J. et al. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia, 55, 1346\u20131354 (2012).","journal-title":"Diabetologia"},{"key":"BFsrep06155_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF01660981","volume":"421","author":"C Rocken","year":"1992","unstructured":"Rocken, C., Linke, R. P. & Saeger, W. Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch. A: Pathol. Anat. Histopathol. 421, 339\u2013344 (1992).","journal-title":"Virchows Arch. A: Pathol. Anat. Histopathol."},{"key":"BFsrep06155_CR6","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper, G. J. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84, 8628\u20138632 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep06155_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","volume":"38","author":"L Marzban","year":"2003","unstructured":"Marzban, L., Park, K. & Verchere, C. B. Islet amyloid polypeptide and type 2 diabetes. Exp. Gerontol. 38, 347\u2013351 (2003).","journal-title":"Exp. Gerontol."},{"key":"BFsrep06155_CR8","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1111\/j.1742-4658.2005.05024.x","volume":"272","author":"P Westermark","year":"2005","unstructured":"Westermark, P. Aspects on human amyloid forms and their fibril polypeptides. FEBES J. 272, 5942\u20135949 (2005).","journal-title":"FEBES J."},{"key":"BFsrep06155_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"BFsrep06155_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JAD-2010-100975","volume":"22 Suppl. 3","author":"VH Finder","year":"2010","unstructured":"Finder, V. H. Alzheimer's disease: a general introduction and pathomechanism. J. Alzheimer' s Dis. 22 Suppl. 3, 5\u201319 (2010).","journal-title":"J. Alzheimer'"},{"key":"BFsrep06155_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.nucmedbio.2011.10.007","volume":"39","author":"MM Svedberg","year":"2012","unstructured":"Svedberg, M. M., Rahman, O. & Hall, H. Preclinical studies of potential amyloid binding PET\/SPECT ligands in Alzheimer's disease. Nucl. Med. Biol. 39, 484\u2013501 (2012).","journal-title":"Nucl. Med. Biol."},{"key":"BFsrep06155_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2967\/jnumed.110.076315","volume":"41","author":"CC Rowe","year":"2013","unstructured":"Rowe, C. C. & Villemagne, V. L. Brain amyloid imaging. J. Nucl. Med. Technol. 41, 11\u201318 (2013).","journal-title":"J. Nucl. Med. Technol."},{"key":"BFsrep06155_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni, G. et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J. Nucl. Med. 54, 213\u2013220 (2013).","journal-title":"J. Nucl. Med."},{"key":"BFsrep06155_CR14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/cbic.200500550","volume":"7","author":"KP Nilsson","year":"2006","unstructured":"Nilsson, K. P. et al. Conjugated polyelectrolytes\u2014Conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem 7, 1096\u20131104 (2006).","journal-title":"Chembiochem"},{"key":"BFsrep06155_CR15","doi-asserted-by":"publisher","first-page":"e74104","DOI":"10.1371\/journal.pone.0074104","volume":"8","author":"M Ono","year":"2013","unstructured":"Ono, M. et al. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of \u03b2-amyloid plaques in Alzheimer's disease. PLoS One 8, e74104 (2013).","journal-title":"PLoS One"},{"key":"BFsrep06155_CR16","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1021\/jm200057u","volume":"54","author":"M Ono","year":"2011","unstructured":"Ono, M. et al. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of \u03b2-amyloid plaques in Alzheimer's brains. J. Med. Chem. 54, 2971\u20132979 (2011).","journal-title":"J. Med. Chem."},{"key":"BFsrep06155_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1021\/ml4000707","volume":"4","author":"M Yoshimura","year":"2013","unstructured":"Yoshimura, M. et al. Structure-activity relationships and in vivo evaluation of quinoxaline derivatives for PET imaging of \u03b2-amyloid plaques. ACS Med. Chem. Lett. 4, 596\u2013600 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"BFsrep06155_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0006-8993(02)03436-4","volume":"956","author":"MP Kung","year":"2002","unstructured":"Kung, M. P. et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of \u03b2-amyloid plaques. Brain Res. 956, 202\u2013210 (2002).","journal-title":"Brain Res."},{"key":"BFsrep06155_CR19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","volume":"50","author":"SR Choi","year":"2009","unstructured":"Choi, S. R. et al. Preclinical properties of 18F-AV-45: a PET agent for A\u03b2 plaques in the brain. J. Nucl. Med. 50, 1887\u20131894 (2009).","journal-title":"J. Nucl. Med."},{"key":"BFsrep06155_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","volume":"32","author":"W Zhang","year":"2005","unstructured":"Zhang, W. et al. F-18 polyethyleneglycol stilbenes as PET imaging agents targeting A\u03b2 aggregates in the brain. Nucl. Med. Biol. 32, 799\u2013809 (2005).","journal-title":"Nucl. Med. Biol."},{"key":"BFsrep06155_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0303-7207(02)00266-6","volume":"197","author":"JW H\u00f6ppener","year":"2002","unstructured":"H\u00f6ppener, J. W., Nieuwenhuis, M. G., Vroom, T. M., Ahren, B. & Lips, C. J. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? Mol. Cell. Endocrinol. 197, 205\u2013212 (2002).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFsrep06155_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.sbi.2012.11.003","volume":"23","author":"P Cao","year":"2013","unstructured":"Cao, P., Abedini, A. & Raleigh, D. P. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. Curr. Opin. Struct. Biol. 23, 82\u201389 (2013).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFsrep06155_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","volume":"31","author":"J Miklossy","year":"2010","unstructured":"Miklossy, J. et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol. Aging 31, 1503\u20131515 (2010).","journal-title":"Neurobiol. Aging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep06155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:06:05Z","timestamp":1672992365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep06155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,21]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep06155"],"URL":"https:\/\/doi.org\/10.1038\/srep06155","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,21]]},"assertion":[{"value":"10 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6155"}}